Kortikotropin-oslobađajući hormonski receptor 2

edit
Kortikotropin-oslobađajući hormonski receptor 2
Identifikatori
SimboliCRHR2; CRFR2
Vanjski IDOMIM: 602034 MGI: 894312 HomoloGene: 55612 IUPHAR: CRF2 GeneCards: CRHR2 Gene
Ontologija gena
Molekulska funkcija receptorska aktivnost
aktivnost G-protein spregnutog receptora
aktivnost kortikotropin-oslobađajućeg hormonskog receptora
Ćelijska komponenta ćelijska membrana
integralno sa ćelijskom membranom
Biološki proces prenos signala
signalni put G-protein spregnutog receptora
G-proteinska signalizacija, spregnuta sa cAMP nukleotidnim sekundarnim glasnikom
Pregled RNK izražavanja
podaci
Ortolozi
VrstaČovekMiš
Entrez139512922
EnsemblENSG00000106113ENSMUSG00000003476
UniProtQ13324Q3UQP0
Ref. Sekv. (iRNK)NM_001883NM_009953
Ref. Sekv. (protein)NP_001874NP_034083
Lokacija (UCSC)Chr 7:
30.66 - 30.71 Mb
Chr 6:
55.02 - 55.06 Mb
PubMed pretraga[1][2]

Kortikotropin-oslobađajući hormonski receptor 2 (CRHR2) je humani protein, takođe poznat kao CRF2, što je IUPHAR-preporučena oznaka.[1]

Vidi još

Literatura

  1. „Entrez Gene: CRHR2 corticotropin releasing hormone receptor 2”. 

Dodatna literatura

  • Perrin MH, Donaldson CJ, Chen R, et al. (1994). „Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.”. Endocrinology 133 (6): 3058–61. DOI:10.1210/en.133.6.3058. PMID 8243338. 
  • Liaw CW, Lovenberg TW, Barry G, et al. (1996). „Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.”. Endocrinology 137 (1): 72–7. DOI:10.1210/en.137.1.72. PMID 8536644. 
  • Donaldson CJ, Sutton SW, Perrin MH, et al. (1996). „Cloning and characterization of human urocortin.”. Endocrinology 137 (5): 2167–70. DOI:10.1210/en.137.5.2167. PMID 8612563. 
  • Meyer AH, Ullmer C, Schmuck K, et al. (1997). „Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis.”. Genomics 40 (1): 189–90. DOI:10.1006/geno.1996.4521. PMID 9070940. 
  • Valdenaire O, Giller T, Breu V, et al. (1997). „A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.”. Biochim. Biophys. Acta 1352 (2): 129–32. PMID 9199241. 
  • Gottowik J, Goetschy V, Henriot S, et al. (1998). „Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.”. Neuropharmacology 36 (10): 1439–46. DOI:10.1016/S0028-3908(97)00098-1. PMID 9423932. 
  • Kostich WA, Chen A, Sperle K, Largent BL (1998). „Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.”. Mol. Endocrinol. 12 (8): 1077–85. DOI:10.1210/me.12.8.1077. PMID 9717834. 
  • Willenberg HS, Bornstein SR, Hiroi N, et al. (2000). „Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.”. Mol. Psychiatry 5 (2): 137–41. DOI:10.1038/sj.mp.4000720. PMID 10822340. 
  • Reyes TM, Lewis K, Perrin MH, et al. (2001). „Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.”. Proc. Natl. Acad. Sci. U.S.A. 98 (5): 2843–8. DOI:10.1073/pnas.051626398. PMC 30227. PMID 11226328. 
  • Hsu SY, Hsueh AJ (2001). „Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.”. Nat. Med. 7 (5): 605–11. DOI:10.1038/87936. PMID 11329063. 
  • Lewis K, Li C, Perrin MH, et al. (2001). „Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.”. Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7570–5. DOI:10.1073/pnas.121165198. PMC 34709. PMID 11416224. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. DOI:10.1073/pnas.242603899. PMC 139241. PMID 12477932. 
  • Scherer SW, Cheung J, MacDonald JR, et al. (2003). „Human chromosome 7: DNA sequence and biology.”. Science 300 (5620): 767–72. DOI:10.1126/science.1083423. PMC 2882961. PMID 12690205. 
  • Wetzka B, Sehringer B, Schäfer WR, et al. (2004). „Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term.”. Exp. Clin. Endocrinol. Diabetes 111 (3): 154–61. DOI:10.1055/s-2003-39778. PMID 12784189. 
  • Hillier LW, Fulton RS, Fulton LA, et al. (2003). „The DNA sequence of human chromosome 7.”. Nature 424 (6945): 157–64. DOI:10.1038/nature01782. PMID 12853948. 
  • Karteris E, Hillhouse EW, Grammatopoulos D (2004). „Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.”. Endocrinology 145 (2): 890–900. DOI:10.1210/en.2003-1210. PMID 14592950. 
  • Seres J, Bornstein SR, Seres P, et al. (2004). „Corticotropin-releasing hormone system in human adipose tissue.”. J. Clin. Endocrinol. Metab. 89 (2): 965–70. DOI:10.1210/jc.2003-031299. PMID 14764822. 
  • Brandenberger R, Wei H, Zhang S, et al. (2005). „Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.”. Nat. Biotechnol. 22 (6): 707–16. DOI:10.1038/nbt971. PMID 15146197. 
  • Nanda SA, Roseboom PH, Nash GA, et al. (2004). „Characterization of the human corticotropin-releasing factor2(a) receptor promoter: regulation by glucocorticoids and the cyclic adenosine 5'-monophosphate pathway.”. Endocrinology 145 (12): 5605–15. DOI:10.1210/en.2004-0907. PMID 15331578. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). „The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).”. Genome Res. 14 (10B): 2121–7. DOI:10.1101/gr.2596504. PMC 528928. PMID 15489334. 

Spoljašnje veze

  • „Corticotropin-releasing Factor Receptors: CRF2”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2015-12-22. 
  • MeSH Corticotropin-releasing+hormone+receptors
  • p
  • r
  • u
Klasa A: Rodopsinu slični
α1 (A, B, D) • α2 (A, B, C) • β1 • β2 • β3
Adenozinski (A1, A2A, A2B, A3) • P2Y (1, 2, 4, 5, 6, 8, 9, 10, 11, 12, 13, 14)
(svi osim 5-HT3) 5-HT1 (A, B, D, E, F) • 5-HT2 (A, B, C) • 5-HT (4, 5A, 6, 7)
Drugi
Acetilholin (M1, M2, M3, M4, M5) • Dopamin (D1, D2, D3, D4, D5) • Histamin (H1, H2, H3, H4) • Melatonin (1A, 1B, 1C) • TAAR (1, 2, 3, 5, 6, 8, 9)
Metaboliti i
signalni molekuli
CysLT (1, 2) • LTB4 (1, 2) • FPRL1 • OXE • Prostaglandin (DP (1, 2), EP (1, 2, 3, 4), FP) • Prostaciklin • Tromboksan
Drugi
Žučna kiselina • Kanabinoidni (CB1, CB2, GPR (18, 55, 119)) • EBI2 • Estrogen • Slobodna masna kiselina (1, 2, 3, 4) • Laktat  • Lizofosfatidna kiselina (1, 2, 3, 4, 5, 6)  • Lizofosfolipid (1, 2, 3, 4, 5, 6, 7, 8) • Niacin (1, 2) • Oksoglutarat • PAF • Sfingozin-1-fosfat (1, 2, 3, 4, 5) • Sukcinat
Peptid
B/W (1, 2) • FF (1, 2) • S • Y (1, 2, 4, 5) • Neuromedin (B, U (1, 2)) • Neurotenzin (1, 2)
Drugi
Anafilatoksin (C3a, C5a) • Angiotenzin (1, 2) • Apelin • Bombezin (BRS3, GRPR, NMBR) • Bradikinin (B1, B2) • Hemokin • Holecistokinin (A, B) • Endotelin (A, B) • Formil peptid (1, 2, 3) • FSH • Galanin (1, 2, 3) • GHB receptor • Gonadotropin-oslobađajući hormon (1, 2) • Grelin • Kispeptin • Luteinizirajući hormon/horiogonadotropin • MAS (1, 1L, D, E, F, G, X1, X2, X3, X4) • Melanokortin (1, 2, 3, 4, 5) • MCHR (1, 2) • Motilin • Opioidni (δ, κ, μ, Nociceptin & ζ, ali ne σ) • Oreksin (1, 2) • Oksitocin • Prokineticin (1, 2) • Prolaktin-oslobađajući peptid • Relaksin (1, 2, 3, 4) • Somatostatin (1, 2, 3, 4, 5) • Tahikinin (1, 2, 3) • Tirotropin • Tirotropin-oslobađajući hormon • Urotenzin-II • Vazopresin (1A, 1B, 2)
Razno
GPR (1, 3, 4, 6, 12, 15, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 31, 32, 33, 34, 35, 37, 39, 42, 44, 45, 50, 52, 55, 61, 62, 63, 65, 68, 75, 77, 78, 81, 82, 83, 84, 85, 87, 88, 92, 101, 103, 109A, 109B, 119, 120, 132, 135, 137B, 139, 141, 142, 146, 148, 149, 150, 151, 152, 153, 160, 161, 162, 171, 173, 174, 176, 177, 182, 183)
Drugi
Adrenomedulin • Mirisni • Opsin (3, 4, 5, 1LW, 1MW, 1SW, RGR, RRH) • Proteazom-aktivirani (1, 2, 3, 4) • SREB (1, 2, 3)
Klasa B: Sekretinu slični
GPR (56, 64, 97, 98, 110, 111, 112, 113, 114, 115, 116, 123, 124, 125, 126, 128, 133, 143, 144, 155, 157)
Drugi
Klasa C: Metabotropni
glutamat / feromon
TAS1R (1, 2, 3) • TAS2R (1, 3, 4, 5, 8, 9, 10, 12, 13, 14, 16, 19, 20, 30, 31, 38, 39, 40, 41, 42, 43, 45, 46, 50)
Drugi
Klasa F:
Frizzled / Zaglađeni
Uvojiti
Frizzled (1, 2, 3, 4, 5, 6, 7, 8, 9, 10)
Zaglađeni
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
Neuropeptidni receptori
Hormonski receptori
Drugi
Opioidni receptori
Drugi neuropeptidni receptori
B trdu: peptidi (nrpl/grfl/cytl/horl), receptori (lgic, enzr, gprc, igsr, intg, nrpr/grfr/cytr), itra (adap, gbpr, mapk), calc, lipd, signalni putevi (hedp, wntp, tgfp+mapp, notp, jakp, fsap, hipp, tlrp)
  • p
  • r
  • u
Holecistokinin
CCKA
Agonisti: Holecistokinin • CCK-4
Antagonisti: Asperlicin • Proglumid • Lorglumid • Devazepid • Deksloksiglumid
CCKB
Agonisti: Holecistokinin • CCK-4 • Gastrin
Antagonisti: Proglumid • CI-988
CRH
CRF1
CRF2
Galanin
GAL1
Agonisti: Galanin • Galaninu-sličan peptid • Galmic • Galnon
GAL2
Agonisti: Galanin • Galaninu-sličan peptid • Galmic • Galnon
GAL3
Agonisti: Galanin • Galmic • Galnon
Grelin
Agonisti: Grelin • Kapromorelin • MK-677 • Sermorelin • SM-130,686 • Tabimorelin
MCH
MCH1
MCH2
Melanokortin
MC1
MC2
Agonisti: ACTH • Kosintropin • Tetrakosaktid
MC3
Agonisti: alfa-MSH • Bremelanotid • Melanotan II
MC4
Agonisti: alfa-MSH • Bremelanotid • Melanotan II • THIQ
Antagonisti: Agutiju srodni peptid
MC5
Agonisti: alfa-MSH • Melanotan II
Neuropeptid S
Agonisti: Neuropeptid S
Antagonisti: SHA-68
Neuropeptid Y
Y1
Agonisti: Neuropeptid Y • Peptid YY
Antagonisti: BIBP-3226
Y2
Agonisti: Neuropeptid Y • Peptid YY
Antagonisti: BIIE-0246
Y4
Agonisti: Neuropeptid Y • Pankreasni polipeptid • Peptid YY
Antagonisti: UR-AK49
Y5
Agonisti: Neuropeptid Y • Peptid YY
Antagonisti: Lu AA-33810
Neurotenzin
NTS1
Agonisti: Neurotenzin • Neuromedin N
Antagonisti: SR-48692 • SR-142,948
NTS2
Agonisti: Neurotenzin
Antagonisti: Levokabastin • SR-142,948
Opioid
vidi Opioidi
Oreksin
OX1
Agonisti: Oreksin-A
Antagonisti: Almoreksant • SB-334,867 • SB-408,124 • SB-649,868
OX2
Agonisti: Oreksin-A
Antagonisti: Almoreksant • SB-649,868 • TCS-OX2-29
Oksitocin
Agonisti: Karbetocin • Demoksitocin • Oksitocin • WAY-267,464
Antagonisti: Atosiban • L-371,257 • L-368,899
Tahikinin
NK1
Agonisti: Supstanca P
Antagonisti: Aprepitant • Befetupitant • Kasopitant • CI-1021 • CP-96,345 • CP-99,994 • CP-122,721 • Dapitant • Ezlopitant • FK-888 • Fosaprepitant • GR-203,040 • GW-597,599 • HSP-117 • L-733,060 • L-741,671 • L-743,310 • L-758,298 • Lanepitant • LY-306,740 • Maropitant • Netupitant • NKP-608 • Nolpitantium • Orvepitant • RP-67,580 • SDZ NKT 343 • Vestipitant • Vofopitant
NK2
Agonisti: Neurokinin A
Antagonisti: GR-159897 • Ibodutant • Saredutant
NK3
Agonisti: Neurokinin B
Antagonisti: Osanetant • Talnetant
Vazopresin
V1A
Agonisti: Dezmopresin • Felipresin • Ornipresin • Terlipresin • Vazopresin
Antagonisti: Konivaptan • Demeklociklin • Relkovaptan
V1B
Agonisti: Felipresin • Ornipresin • Terlipresin • Vazopresin
Antagonisti: Demeklociklin • Nelivaptan
V2
Agonisti: Dezmopresin • Ornipresin • Vazopresin
Antagonisti: Konivaptan • Demeklociklin • Liksivaptan • Mozavaptan • Satavaptan • Tolvaptan